CTLA4 and anterior uveitis: Compared to monotherapy via PD-1 and PD-L1 inhibitors alone, patients undergoing CTLA-4 inhibitor monotherapy developed anterior uveitis three times faster (all within 20 days in this latter cohort) [74].